Wesley A. Wierson, PhD

Wesley A. Wierson, PhD has an extensive work experience. In 2018, they founded and became the CEO of LEAH Laboratories, a company revolutionizing companion animal medicine with living therapies, and also served as a consultant for Lifengine Technologies. From 2014 to 2018, they were a Doctor of Philosophy at Iowa State University, where their thesis work centered on using zebrafish as an in vivo vertebrate bioreactor to develop technologies that enhance designer nuclease based genome writing. In 2013, they were a Plant Transformation/Molecular Biology Intern at DuPont Pioneer. From 2011 to 2014, they were an Undergraduate Research Assistant at Iowa State University, where they aided lab scientists in their work developing designer TAL effectors and TAL effector nuclease constructs.

Wesley A. Wierson, PhD, obtained their Doctor of Philosophy from Iowa State University in 2019, specializing in Molecular, Cellular, and Developmental Biology. Prior to this, they obtained their Bachelor of Science from Iowa State University in 2013, specializing in Microbiology.